World Congress on Gastrointestinal Cancer:
Asian Perspectives
In conjunction with KACO/KCSG Annual Review:
2011 Advances in Oncology
August 26-27, 2011
Seoul, South Korea
Chairs: Yoon-Koo Kang, MD, PHD and Eric Van Cutsem, MD, PhD
Friday, 26 August, 2011
Session I: Epidemiology
Moderators: Eric Van Cutsem, MD, PhD and
Yoon-Koo Kang, MD, PhD
8:00
Welcome and introduction
Eric Van Cutsem, MD, PhD and
Yoon-Koo Kang, MD, PhD
8:05
Epidemiology and causes of GI cancer
Aesun Shin, MD, PhD
Session II: Esophageal cancer
Moderator: Virote Sriuranpong, MD, PhD
8:25
The role of endoscopic resection management
Haruhiro Inoue, MD, PhD, FASGE
8:45
Bi- and tri-modality management of esophageal cancer
Jong Hoon Kim, MD, PhD
9:05
Case discussion on the management of esophageal cancer
Virote Sriuranpong, MD, PhD,
Haruhiro Inoue, MD, PhD, FASGE and
Jong Hoon Kim, MD, PhD
9:30
Break and poster viewing
Session III: Gastric cancer
Moderator: Yoon-Koo Kang, MD, PhD
10:00
Diagnosis and endoscopic management of early gastric cancer
Hwoon-Yong Jung, MD, PhD, AGAF
10:20
Surgical management of gastric cancer
Han-Kwang Yang, MD, PhD, FACS
10:45
Meta-analysis of metastatic gastric cancer
Kohei Shitara, MD
11:05
Management of adjuvant and neoadjuvant gastric cancer
Atsushi Ohtsu, MD, PhD
11:30
Session III adjourns
11:45
Luncheon satellite symposium
Supported by Novartis Oncology
Improving patient outcomes in gastric, advanced NET, and HCC: The importance of phase III clinical trials
12:45
Satellite symposium adjourns
13:00
Presentation of selected abstract
Efficacy and tolerability of bevacizumab (BEV) plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer (AGC): Results from the randomized, double-blind, multicenter AVATAR study O-0001
13:15
Abstract discussion
Yoon-Koo Kang, MD, PhD
Session IV: Hepatocellular carcinoma
Moderator: Ann-Lii Cheng, MD, PhD
13:25
Treatment algorithms for HCC
Japanese perspective:
Takuji Okusaka, MD, PhD
Korean perspective:
Joong-Won Park, MD, PhD
Singapore perspective:
Alex Y. Chang, MD
14:10
Radiotherapy techniques in HCC
Jinsil Seong, MD, PhD
14:30
Break and poster viewing
Session V: Biliary tract and pancreatic cancer
Moderator: Anthony TC Chan, MD, FRCP
14:50
Advances in surgical treatment for pancreatic cancers
Song Cheol Kim, MD
15:10
Current options of systemic therapy for pancreatic cancer
Stephen L. Chan, MD
15:30
Current options of systemic therapy for biliary tract cancer
Jin Li, MD, PhD
15:50
Clinical and translational research in biliary and pancreatic cancers
Li-Tzong Chen, MD, PhD
Session VI: Rare gastrointestinal malignancies
Moderator: Yoon-Koo Kang, MD, PhD
16:15
Modern management of GIST
Yoon-Koo Kang, MD, PhD
16:35
Medical management of NET
Young Suk Park, MD, PhD
16:55
Case discussion on rare gastrointestinal malignancies
Yoon-Koo Kang, MD, PhD and
Young Suk Park, MD, PhD
17:20
Closing remarks and adjourn
Saturday, 27 August 2011
Session VII: Localized colorectal cancer
Moderator: Eric Van Cutsem, MD, PhD
8:45
Welcome and introduction
Eric Van Cutsem, MD, PhD and
Yoon-Koo Kang, MD, PhD
8:50
Neoadjuvant and adjuvant therapy
Tae-Won Kim, MD, PhD
Session VIII: Advanced colorectal cancer
Moderator: Anthony TC Chan, MD, FRCP
9:10
What is the optimal cytotoxic regimen in advanced colorectal cancer?
Brigette Ma, MBBS, FRACP
9:30
Predictive molecular markers in colorectal cancer
Mario Dicato, MD
9:50
EGFR inhibitors in metastatic colorectal cancer
Eric Van Cutsem, MD, PhD
10:10
Break
10:35
Angiogenesis inhibitors in metastatic colorectal cancer
Brigette Ma, MBBS, FRACP
10:55
Optimal neoadjuvant chemotherapy for the management of liver metastases
Alex Y. Chang, MD
11:15
Case discussion on the management of colorectal cancer
Panel: Anthony TC Chan, MD, FRCP and
Stephen L. Chan, MD
11:35
Session VIII adjourns
11:50
Luncheon satellite symposium
Supported by Taiho Pharmaceutical Co., Ltd.
The latest evidence of gastrointestinal cancer chemotherapy
12:50
Satellite symposium adjourns
Session IX: Joint session – 2011 Highlights
Joint session in collaboration with KACO/KCSG Annual Review: 2011 Advances in Oncology
13:00
Gastric and esophageal cancer highlights
Sun Young Rha, MD, PhD
13:30
Colorectal cancer highlights
Eric Van Cutsem, MD, PhD
14:00
Biliary and pancreatic cancer highlights
Myung-Ah Lee, MD, PhD
14:30
Markers in upper GI cancer highlights
Mario Dicato, MD
15:00
Adjourn joint session





